From: Transcriptional expression of 8 genes predicts pathological response to first-line docetaxel + trastuzumab-based neoadjuvant chemotherapy
Predicted
pCR
Non-pCR
Total
Observed
12
6
18
5
22
27
17
28
45
Cases
Percentage
Sensitivity
12/18
67
Specificity
22/27
82
Positive predictive value
17/18
94
Negative predictive value
28/27
104
Accuracy
34/45
76